These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32596727)

  • 1. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
    Panopoulos S; Thomas K; Georgiopoulos G; Boumpas D; Katsiari C; Bertsias G; Drosos AA; Boki K; Dimitroulas T; Garyfallos A; Papagoras C; Katsimbri P; Tziortziotis A; Adamichou C; Kaltsonoudis E; Argyriou E; Vosvotekas G; Sfikakis PP; Vassilopoulos D; Tektonidou MG
    Rheumatology (Oxford); 2021 Jan; 60(1):170-178. PubMed ID: 32596727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.
    Panopoulos S; Tektonidou M; Drosos AA; Liossis SN; Dimitroulas T; Garyfallos A; Sakkas L; Boumpas D; Voulgari PV; Daoussis D; Thomas K; Georgiopoulos G; Vosvotekas G; Vassilopoulos D; Sfikakis PP
    Arthritis Res Ther; 2018 Dec; 20(1):267. PubMed ID: 30514359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus.
    Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34921093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus.
    Fragoulis GE; Evangelatos G; Tentolouris N; Fragkiadaki K; Panopoulos S; Konstantonis G; Iliopoulos A; Chatzidionysiou K; Sfikakis PP; Tektonidou MG
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20976975. PubMed ID: 33343726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.
    Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
    Front Immunol; 2022; 13():1077166. PubMed ID: 36700208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Occurrence of cardiovascular events within a large population of patients affected by rheumatoid arthritis with or without diabetes.].
    Calabria S; Ronconi G; Dondi L; Piccinni C; Pedrini A; Dondi L; Dell'Anno I; Esposito I; Addesi A; Martini N; Maggioni AP
    Recenti Prog Med; 2023 Feb; 114(2):94-109. PubMed ID: 36700719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.
    Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
    Semin Arthritis Rheum; 2018 Jun; 47(6):883-889. PubMed ID: 29150207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
    Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke?
    Camargo EW; Freire PV; Silva CA; dos Santos NR; da Mota LM; Pereira RM; de Carvalho JF
    Rheumatol Int; 2012 Jun; 32(6):1721-5. PubMed ID: 21437687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.
    Batko B; Urbański K; Świerkot J; Wiland P; Raciborski F; Jędrzejewski M; Koziej M; Cześnikiewicz-Guzik M; Guzik TJ; Stajszczyk M
    Clin Rheumatol; 2019 Sep; 38(9):2473-2481. PubMed ID: 31076943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Chamberlain AM; Alonso A; Gersh BJ; Manemann SM; Killian JM; Weston SA; Byrne M; Roger VL
    Am Heart J; 2017 Mar; 185():74-84. PubMed ID: 28267478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.
    Aurrecoechea E; Llorca Díaz J; Diez Lizuain ML; McGwin G; Calvo-Alen J
    Rheumatol Int; 2017 Apr; 37(4):479-485. PubMed ID: 27987002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
    Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
    Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3 year prospective study.
    Evangelatos G; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
    Rheumatology (Oxford); 2022 Aug; 61(8):3408-3413. PubMed ID: 34850863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
    Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
    Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
    Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between cerebrovascular and valvular manifestations in a Serbian cohort of patients with antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Stanisavljevic N; Banicevic S; Smiljanic D; Milovanovic B
    Clin Exp Rheumatol; 2018; 36(5):850-855. PubMed ID: 29846156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study.
    Warrington KJ; Kent PD; Frye RL; Lymp JF; Kopecky SL; Goronzy JJ; Weyand CM
    Arthritis Res Ther; 2005; 7(5):R984-91. PubMed ID: 16207339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity in psoriatic arthritis and rheumatoid arthritis.
    Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).
    Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch MH; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Luo SF; Kurucz R; Maciel G; Mola EM; Montecucco CM; McInnes I; Radner H; Smolen JS; Song YW; Vonkeman HE; Winthrop K; Kay J
    Ann Rheum Dis; 2014 Jan; 73(1):62-8. PubMed ID: 24095940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.